BioSpace News Archive

Rashid A. Bux, President and CEO of BioMark, says, “This publication shows the potential of our liquid biopsy platform’s ability to provide a novel and low-cost test to quickly assess a patient’s response to cancer treatment so that clinicians can adjust the treatment regimen accordingly.

Follow up to landmark 2011 study shows children who had prenatal repair also have better self-care skills and are more independent up to 10 years later

The Acceptance of Bitcoin, and Possibly Other Select Cryptocurrencies, Will Improve the Company’s Ability to Transact With Customers Throughout the World

Today, the American Diabetes Association® (ADA) and the Baxter International Foundation, the philanthropic arm of Baxter International Inc., announced a new partnership as part of the ADA’s Health Equity Now (HEN) platform to address health disparities for people with diabetes in Chicago’s underserved Black communities

Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (OTCQB: CHMJF) is pleased to inform shareholders that Chemistree investee ImmunoFlex™ has today announced that it is receiving advisory services and conditional research and development funding from the National Research Council

The largest incentive prize in history to attract and inspire innovators to develop and scale carbon removal solutions to combat climate change.

Amicus Optimized Transgene Show Greater Substrate Reduction than Wild Type Construct Across All Tissues and Doses Further Validates Combining Amicus-Engineered Transgenes with Penn’s AAV Gene Therapy Technologies to Develop Next Generation Gene Therapies

- RGX-121, a one-time gene therapy for MPS II, continues to be well-tolerated with no drug-related serious adverse events - Biomarkers and measures of neurodevelopmental function from patients in Cohort 1 and 2 indicate CNS activity following RGX-121 administration -- Consistent reductions in CSF levels of biomarkers up to 2 years after RGX-121 administration

- IND-Enabling Studies Demonstrated Potential of a Single I.V. Administration of HMI-203 to Address Peripheral and CNS Components of Disease - - Data at WORLD Symposium ™ Support Plans to Initiate a HMI-203 Phase 1/2 Clinical Trial This Year

Metazoa, developers of the Salesforce ecosystem’s top software toolset for org management, today announced that Metazoa Snapshot has been optimized to support Salesforce Vaccine Cloud.